Intuitive Surgical (NasdaqGS:ISRG) recently secured CE Mark approval for its da Vinci 5 Surgical System, enabling advanced robotic-assisted surgical procedures in Europe. This positive development ...

Intuitive Surgical is set to release its second-quarter results next month, with analysts projecting single-digit growth in ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Intuitive Surgical. If we consider the specifics of each trade, it is accurate to state that 11% of the investors opened ...

Intuitive Surgical’s stock has skyrocketed 178% in five years, outpacing its earnings growth, and impressing investors across ...

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci ...

Medtronic's growth strategies, dividend stability, and innovation focus amidst debt concerns and market risks. Click here to ...

Intuitive Surgical, a leader in robotic-assisted surgery, is preparing to report its fiscal Q2 2025 earnings on July 17.

Intuitive Surgical has a trailing 12 month Price to Earnings (P/E) ratio of 79.1 while the S&P 500 average is 29.3 Its ...

The robotics giant’s most advanced soft tissue surgical system is now available for use in Europe across a range of ...

Intuitive Surgical (Nasdaq: ISRG) announced today that it received CE mark for its da Vinci 5 surgical robotic system.

Intuitive Surgical ISRG recently received CE mark approval for its latest da Vinci 5 Surgical System. This approval ...

Intuitive Surgical Inc. closed 11.78% short of its 52-week high of $616.00, which the company achieved on January 23rd.